An analysis of nearly half a million cells from dozens of patients' tumors reveals how cancer cells continuously reshape their genetic makeup over time, enabling them to evade treatment for one of the ...

Ralph V. Boccia, MD, FACP, explained why CAR T-cell therapy followed by bispecific antibodies may be the preferred sequence at first relapse in multiple myeloma.

Researchers have developed an optimized tumor-infiltrating lymphocyte manufacturing protocol that shows preclinical efficacy ...

I f your doctor has recommended chimeric antigen receptor (CAR) T-cell immunotherapy for large B-cell lymphoma (LBCL), you’ve likely already tried several standard treatments, and the cancer did not ...

A research team has developed a combination immunotherapy that uses an electrical ablation technique to enhance the efficacy ...

Researchers in Adelaide and Singapore have uncovered new clues as to why some people with chronic myeloid leukemia (CML) ...

A new review in Molecular Biology Reports argues that DNA methylation silencing of the TRAIL pathway components DR5, DcR2, ...

CAF Crosstalk to Reprogram the tumor microenvironment (TME). Ctx-ETAC suppresses EV secretion, disrupts cancer-CAF ...

A 20-year-old woman with relapsed leukaemia has received the treatment at TU Teaching Hospital. Doctors are monitoring her ...

Scientists at UC San Francisco have developed a way to create cancer-fighting CAR-T cells directly inside the body, potentially avoiding the slow and extremely expensive process of removing, ...

The safety profile is one of the biggest advantages of CAR NK cells, and that is exciting for the field because NK cells do ...